Early recognition of ipilimumab‐related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management

Publisher： John Wiley & Sons Inc

E-ISSN： 1743-7563|11|2|190-194

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.11, Iss.2, 2015-06, pp. : 190-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ipilimumab‐induced hypophysitis in melanoma patients: an Australian case series

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1066-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-05 ,pp. : 285-288

Karger

Access to resources Recommend Favorite

Febrile Neutropenia in a Metastatic Melanoma Patient Treated with Ipilimumab - Case Report

By  

Oncology Research and Treatment, Vol. 38, Iss. 3, 2015-02 ,pp. : 105-108

Karger

Access to resources Recommend Favorite

Clinical activity of ipilimumab for metastatic uveal melanoma

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3687-3695

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation‐positive metastatic melanoma, including recognition and management of rare presentations

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 4, 2015-10 ,pp. : 1024-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite